Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02099552 · ClinicalTrials.gov registry record
Natural History and Outcomes in X-Linked Hypohidrotic Ectodermal Dysplasia
A clinical trial, sponsored by Edimer Pharmaceuticals.
- Completed
- Registry status
- 150
- Enrollment target
NCT02099552: Completed study, sponsored by Edimer Pharmaceuticals.
NCT02099552 is a clinical trial that has completed, run by Edimer Pharmaceuticals. The registered enrollment target is 150 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02099552 has completed, sponsored by Edimer Pharmaceuticals.
- COMPLETED
- Registry status
- 150 participants
- Enrollment target
Study Summary
The proposed natural history study will enroll male and female patients, ages 36 months and younger, who have a diagnosis of XLHED based on genetic testing and who have not received an investigational study drug. The study protocol will include collection of all relevant medical history and documentation of clinical outcomes using age-appropriate, minimally invasive technologies. Data will be collected both retrospectively, back to pregnancy assessments that may be available, and prospectively through age 5 yrs.
Primary Outcome
To characterize the clinical course of untreated XLHED male and female subjects in early childhood, capturing data from physician and hospital records, medical history including growth and development, and family interviews.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 150 participants |
| Start Date | 2014-04 |
| Est. Completion | 2016-12 |
What the finished NCT02099552 record still lists
NCT02099552 is an observational study that tracks outcomes without assigning an intervention. The registered 150 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 0 interventions.
NCT02099552 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02099552 about?
NCT02099552 is a clinical study titled "Natural History and Outcomes in X-Linked Hypohidrotic Ectodermal Dysplasia". The proposed natural history study will enroll male and female patients, ages 36 months and younger, who have a diagnosis of XLHED based on genetic testing and who have not received an investigational study drug. The study protocol will include collection of all relevant medical history and document...
What is the current status of trial NCT02099552?
This trial is currently completed. The enrollment target is 150 participants. The study started on 2014-04. Estimated completion is 2016-12.
Who is sponsoring clinical trial NCT02099552?
This trial is sponsored by Edimer Pharmaceuticals, which has 11 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00412594 · 150 participants · Phase 2
Cladribine and Rituximab in Treating Patients With Hairy Cell Leukemia
- NCT01484730 · 150 participants
A Pilot Study to Evaluate Multi-Spectral and Laser Speckle Imaging and Multiphoton Microscopy During Vascular Occlusion
- NCT01985919 · 150 participants
Protocol for Facilitating the Acquisition of Research Bone Marrow and Blood Samples
- NCT02016248 · 150 participants · NA
SBRT Boost for Unfavorable Prostate Cancer'
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia